CPG
IDNA icon

Custom Portfolio Group’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Custom Portfolio Group’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$691K Sell
31,308
-340
-1% -$7.96K 0.54% 22
2024
Q1 		$725K Buy
+31,648
New +$742K 0.6% 19

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Custom Portfolio Group's IDNA Position: Q2 2024 in Review

Custom Portfolio Group reduced its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 1.1% in Q2 2024, selling an estimated $7.96K and leaving 31,308 shares worth $691K. The position accounts for 0.54% of the portfolio, ranked #22.

Custom Portfolio Group first reported a position in IDNA in Q1 2024 and has held it in 2 quarters since. The position peaked at $725K in Q1 2024. 62 funds tracked by Wall St. Rank hold IDNA as of Q2 2024.

  • Custom Portfolio Group held 31,308 shares of iShares Genomics Immunology and Healthcare ETF worth $691K as of Q2 2024.
  • Custom Portfolio Group sold 340 iShares Genomics Immunology and Healthcare ETF shares in Q2 2024, an estimated $7.96K.
  • iShares Genomics Immunology and Healthcare ETF made up 0.54% of Custom Portfolio Group's portfolio in Q2 2024, its #22 holding.
  • Custom Portfolio Group first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2024 and has held it in 2 quarters since.
  • Custom Portfolio Group's iShares Genomics Immunology and Healthcare ETF position peaked at $725K in Q1 2024.
  • 62 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2024.

Based on Custom Portfolio Group's 13F filing for Q2 2024, filed 27 Aug 2024.